Back to publication

The Cameroon Mobile Phone SMS (CAMPS) Trial: A Randomized Trial of Text Messaging versus Usual Care for Adherence to Antiretroviral Therapy

Assessed by RV004 · Research Assistant

Assessed on 3 Nov 2025

OverallReviewer's overall integrity assessment, derived from all research questions Some concerns

DOI 10.1371/journal.pone.0046909 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEA1195AD8EF5C09D44

5 Research Questions · 4 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsN/A

Rationale: No rationale provided

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsN/A

Rationale: No rationale provided

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsN/A

Rationale: No rationale provided

Supporting Evidence (2)

Retraction NoticeSource: Retraction Watch database

Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis

10.1093/ecco-jcc/jjab227 (opens in new tab)
Journal: Journal of Crohn's and ColitisPublisher: Oxford AcademicDate: 24 Jan 2022

RetractionWatch ID:Record identifier in the Retraction Watch database 35137

Rationale: Civil Proceedings;Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Legal Reasons and/or Threats

About Author: Edward Mills

Retraction NoticeSource: Retraction Watch database

Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial

10.1016/j.lana.2024.100703 (opens in new tab)
Journal: The Lancet Regional Health - AmericasPublisher: ElsevierDate: 22 Feb 2024

RetractionWatch ID:Record identifier in the Retraction Watch database 60864

Rationale: Error in Data

About Authors: Lehana Thabane, Edward Mills

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsN/A

Rationale: No rationale provided

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: PACTR201011000261458

Registry: PACTR

Registry Link: https://trialsearch.who.int/Trial2.aspx?TrialID=PACTR201011000261458 (opens in new tab)

Registration Date: 11 Nov 2010

Prospective:Whether the trial was registered before participant recruitment began Yes

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is on or before LLM recruitment start date.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 22-11-2010

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Methods: 'Participants were enrolled from the waiting rooms of the YCH ATC from the 22 November to the 22 December, 2010.'

Recruitment End: 22-12-2010

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date Methods: 'Participants were enrolled from the waiting rooms of the YCH ATC from the 22 November to the 22 December, 2010.'

Study End: 05-2011

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Results: 'Participants were followed up from December 2010 to May 2011, when the intervention was stopped.'

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsSome concerns

Rationale: There are some concerns about certain papers published by the authors. However, these concerns originated from the authors' group directly, and they have reported that they are working on addressing them. Importantly, these issues do not affect the current study, as they are unrelated. Nevertheless, I am unsure whether I will use this study or not.